Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   


The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (

Term:leukemia incidence/prevalence measurement
go back to main search page
Accession:CMO:0001266 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display leukemia, any of a group of progressive, malignant diseases of the blood-forming organs, marked by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow, at a point in time or develop leukemia within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio.
Synonyms:xref: MESH:D007938

show annotations for term's descendants           Sort by:

Term paths to the root